Mimedx (MDXG) Profit After Tax (2011 - 2026)

Mimedx (MDXG) has 16 years of Profit After Tax data on file, last reported at -$10.9 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 254.63% year-over-year to -$10.9 million; the trailing twelve-month figure through Mar 2026 stood at $30.7 million (down 22.36% YoY), and the FY2025 full-year result was $48.6 million, up 15.67% from the prior year.
• Profit After Tax declined to -$10.9 million in Q1 2026, from $15.2 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $53.5 million in Q4 2023 to a low of -$12.5 million in Q2 2022.
• A 5-year average of $6.3 million and a median of $7.0 million in 2025 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax tumbled 602.42% in 2022 and jumped 13017.15% in 2023, its largest moves.
• Tracing MDXG's Profit After Tax over 5 years: stood at -$414000.0 in 2022, then jumped by 13017.15% to $53.5 million in 2023, then plunged by 86.88% to $7.0 million in 2024, then jumped by 116.49% to $15.2 million in 2025, then sank by 171.49% to -$10.9 million in 2026.
• Business Quant data shows MDXG's Profit After Tax at -$10.9 million in Q1 2026, $15.2 million in Q4 2025, and $16.7 million in Q3 2025.